MITTEL GEGEN MALARIA
European patent · EP4013742 · In force
Register entry
- Publication number
- EP4013742
- Application number
- EP20852190
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 21, 2020
- Published
- Jun 22, 2022
- Granted
- Aug 19, 2026
- Protection ends at the latest
- Jul 20, 2040
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07D 239/22 (2006.01)C07D 405/04 (2006.01)C07D 405/12 (2006.01)C07D 405/14 (2006.01)C07D 409/04 (2006.01)C07D 409/14 (2006.01)A61K 31/513 (2006.01)A61P 33/06 (2006.01)
- Priority
- WO PCT/CN2019/100781 15.08.2019
- PCT application
- PCT/CN2020/103178 21.07.2020
- PCT publication
- WO2021/027502 18.02.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 2, 2026
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 02.10.2026
- Aug 19, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 19.08.2026
Parties
Holder
Inventor
West Point, Pennsylvania 19486, US
Parkville, Victoria 3052, AU
West Point, Pennsylvania 19486, US
Parkville, Victoria 3052, AU
Kenilworth, New Jersey 07033, US
Shanghai 200131, CN
West Point, Pennsylvania 19486, US
Shanghai 200131, CN
West Point, Pennsylvania 19486, US
Parkville, Victoria 3052, AU
Parkville, Victoria 3052, AU
Parkville, Victoria 3052, AU
Shanghai 200131, CN
Shanghai 200131, CN
Beijing 100020, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.